NOVOZYMES A/S: cashflow_investing

Value{"amount": -1579700000.0, "concept": "ifrs-full:CashFlowsFromUsedInInvestingActivities"}
Period2025-01-01 – 2025-06-30
Statuscurrent
EntityNOVOZYMES A/S
Provenance
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference: esef:529900T6WNZXD2R3JW38:2025-06-30
Retrieved: 2026-08-23T23:02:05.150702+02:00
Raw response sha256: c8e95e08e2a4ef338b66b87733882a24…
Cite as: FACTANKER, https://factanker.com/fact/1a7badf6-bb51-45c2-aff9-b5a6c7e2f8f3

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies